Where is Agrithera located?

Agrithera is headquartered in Tucker, United States.

Is Agrithera a funded company?

Agrithera is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Agrithera rank among its competitors?

Agrithera ranks 2386th amongst 2626 active competitors, of which 890 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of Agrithera?

Agrithera's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Karyopharm secured the most recent funding round in March, 2026.

Agrithera - 2026 Company Profile, Team, Funding & Competitors

Agrithera is a funded company based in Tucker (United States), founded in 2019 by Stephen Traynelis and Dennis Liotta. It operates as a Provider of cannabis-based therapeutics for pain and neurological disorders. The company has 2626 active competitors, including 890 funded and 667 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

Provider of cannabis-based therapeutics for pain and neurological disorders. The company has proprietary CBD technology for developing therapeutics to treat pain, seizure, anxiety, and other disorders.

Website: agrithera.com
Email ID: *****@agrithera.com

Key Metrics

Founded Year

2019

Location

Tucker, United States

Stage

Funding Raised

Investors

Georgia Research Alliance

Ranked

2386^th among 2626 active competitors

Similar Companies

Xenon Pharmaceuticals & 283 more

View Agrithera's full profile

Agrithera is a funded company. Agrithera has 1 institutional investor.

View details of Agrithera's funding rounds and investors

The founders of Agrithera are Stephen Traynelis and Dennis Liotta.

Here are the details of Agrithera's key team members:

Stephen Traynelis: Co-Founder of Agrithera.
Dennis Liotta: Co-Founder of Agrithera.

View details of Agrithera's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Agrithera include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Agrithera, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	Boxer Capital, BVF Partners & 15 others	72/100
4th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Nextech Invest, Third Rock Ventures & 20 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
8th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
9th	Zymeworks 2003, Vancouver (Canada), Public	Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer	$146M	CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund ... & 17 others	71/100
10th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Efung Capital & 5 others	71/100
2386th	Agrithera 2019, Tucker (United States), Funding Raised	Provider of cannabis-based therapeutics for pain and neurological disorders	-	Georgia Research Alliance	22/100